Wedbush Reiterates “Outperform” Rating for Generation Bio (NASDAQ:GBIO)

Generation Bio (NASDAQ:GBIO – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Wedbush in a research report issued on Thursday,RTT News reports. They currently have a $5.00 price target on the stock. Wedbush’s price target suggests a potential upside of 110.08% from the company’s current price. Separately, Needham & Company […]

Leave a Reply

Your email address will not be published.

Previous post Here’s a listing of Veterans Day events around the Twin Cities
Next post Recursion Pharmaceuticals (NASDAQ:RXRX) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS